Furthermore, we noticed that the protein levels of cancer stem cell markers ALDH1 and CD44 were also decreased in the M1-20-treated cancer tissues (Supplemental Fig. 6H), implicating that the population of cancer stem cells in the grafted cancers were altered by the M1-20 treatment. The gene discussed is CD44; the disease is cancer.